• VIX
    Loading…
  • BIST 100
    Loading…
  • UST Yield 10y
    Loading…
  • S&P 500
    Loading…
  • Brent Oil
    Loading…
  • XAU/TRY
    Loading…
  • EUR/TRY
    Loading…
  • USD/TRY
    Loading…
  • XAU/USD
    Loading…
  • EUR/USD
    Loading…

/

Category

/

Intel's 18A-P chip just entered production and the comeback math is real

Intel's 18A-P chip just entered production and the comeback math is real

Photo: Pok Rie

Intel just moved its most important manufacturing technology into early production, and the timing matters more than the technical jargon suggests.

The company announced Tuesday that its 18A-P process has entered what the industry calls "risk production," meaning real chips are being made on real equipment before full commercial volume begins. For a company that spent the better part of a decade watching rivals like TSMC pull ahead on chip manufacturing, this is the moment Intel has been promising for years.

What 18A-P actually is

The 18A-P process is an upgrade to Intel's existing 18A technology. Compared to its predecessor, it delivers 9% higher performance at the same power level, or 18% lower power consumption at the same speed, along with better heat management and more design flexibility. Crucially, chips designed for 18A can run on 18A-P without starting from scratch, which matters a great deal to potential customers who have already invested in design work.

That last point is strategically significant. Intel is not just building chips for itself anymore. CEO Lip-Bu Tan has shifted course from his earlier position, and Intel is now actively pitching 18A-P to outside companies who want someone other than TSMC or Samsung to manufacture their chips. By entering production now, Intel is showing potential clients something concrete rather than a roadmap slide.

Why this matters beyond Intel's stock price

The chip manufacturing industry is one of the few places where geography, national security, and consumer electronics all collide in the same factory. The United States has essentially one major advanced chip manufacturer trying to compete at the frontier: Intel. TSMC, which makes chips for Apple, Nvidia, and most of the AI industry, is Taiwanese. Samsung is South Korean.

Washington has spent tens of billions of dollars under the CHIPS Act trying to change that picture, and Intel is the primary American bet. If 18A-P attracts serious outside customers, it means American soil could eventually manufacture chips for AI servers, military systems, and consumer devices that currently depend on overseas production.

That is not a guarantee. Intel still needs to prove it can manufacture at scale with the defect rates and yields that large customers require. Moving into risk production is an early step, not a finish line.

The demand signal underneath the announcement

Intel also reported that demand for its central processors from companies running AI services was strong enough in the first quarter that it sold chips it had originally written off as unsellable. That is a specific, unusual data point. It suggests the AI infrastructure buildout is pulling in more chip supply than the market had planned for, and that Intel's older products still have buyers even as the newer technology comes online.

The company's revenue forecast for the current quarter runs from $13.8 billion to $14.8 billion, well above the $13.07 billion analysts had expected.

What to watch

The real test arrives when Intel names an outside customer willing to commit volume to 18A-P. A design win from a major technology company would confirm that Intel's manufacturing is competitive, not just functional. Without that, the announcement remains a milestone on an internal roadmap rather than evidence of a genuine turnaround in the foundry business.

Intel has announced milestones before and stumbled on execution. The company's credibility with outside customers was damaged over years of delays, and rebuilding it requires proof that scales, not just proof of concept. The next six to twelve months will show whether entering production was a turning point or another chapter in a longer recovery story.